Best Medical Billing Companies for Infectious Disease Practices in Austin TX

Infusion billing may involve separate codes for the drug, administration service, time or service type, units, and related evaluation and management work. The correct selection depends on the therapy, route, documentation, payer rules, and whether the service is an infusion, injection, or another administration method. Practices should verify current coding guidance and ensure clinical documentation supports every billed service.

No. CPT 96372 is generally associated with a therapeutic, prophylactic, or diagnostic injection administered subcutaneously or intramuscularly, rather than an intravenous infusion. Code selection still depends on the actual route, service performed, documentation, and current payer guidance. Practices should distinguish injection administration from infusion administration and review the complete claim for drug, units, and supporting documentation.

Common needs include charge entry, coding review, claim submission, rejection clearing, eligibility verification, prior authorization, denial appeals, payment reconciliation, and A/R follow-up. Infectious disease practices may also need support reviewing infusion, OPAT, specialty drug, hospital consult, and E/M workflows. The appropriate scope depends on which revenue-cycle functions the practice performs internally and where unresolved claims or missed charges are occurring.

Infusion billing can require coordination of the medication, administration service, units, route, documentation, authorization, and applicable medical or pharmacy benefit. Office visit billing centers more directly on the evaluation and management service. Because infusion claims may combine multiple charge components, practices should confirm that documentation, charge capture, coding, authorization, and payer requirements align before submission.

Revenue leakage can occur when visits are under-leveled, drugs or administration services are not captured, authorization is incomplete, claims are rejected, payments are underpaid, or balances are not pursued. Infectious disease practices may be especially exposed when cognitive services operate alongside infusion, OPAT, and buy-and-bill workflows. Reporting by payer, provider, and service line can help trace where revenue is being lost or delayed.

Yes. Billing support may address OPAT eligibility, authorization, documentation, drug and administration claims, payer coverage, collections, and workflow coordination. OPAT arrangements can involve several participants and revenue considerations, so the practice should clarify which services it provides, which party bills, and what documentation and payer requirements apply. A workflow review can identify gaps before they lead to unreimbursed work.

A payment review compares reimbursement received with the amount expected under the applicable contract, fee schedule, or coverage agreement. For infectious disease services, the review may examine drug, infusion administration, E/M, consult, unit, and NDC details. Findings should be documented by payer and claim, then disputed or escalated according to the practice’s agreement and internal follow-up process.

Look for demonstrated understanding of infectious disease workflows, including infusion, OPAT, specialty drugs, hospital consults, authorization, and revenue-cycle reporting. A suitable partner should explain its coding review, claim follow-up, denial, payment reconciliation, data handling, and communication processes clearly. Practices should also confirm whether the service supports their systems and whether its recommendations distinguish verified information from assumptions or generalized benchmarks.